PPIST13666
Protein Information
| Protein_Chain | A[auth D] |
|---|---|
| Protein_Sequence | MREVRTIKVFTTVDNINLHTQVVDMSMTYGQQFGPTYLDGADVTKIKPHNSHEGKTFYVLPNDDTLRVEAFEYYHTTDPSFLGRYMSALNHTKKWKYPQVNGLTSIKWADNNCYLATALLTLQQIELKFNPPALQDAYYRARAGEAANFCALILAYCNKTVGELGDVRETMSYLFQHANLDSCKRVLNVVCKTCGQQQTTLKGVEAVMYMGTLSYEQFKKGVQIPCTCGKQATKYLVQQESPFVMMSAPPAQYELKHGTFTCASEYTGNYQCGHYKHITSKETLYCIDGALLTKSSEYKGPITDVFYKENSYTTTIKPLEHHHHHH |
Peptide Information
| Peptide_Chain | B[auth I] |
|---|---|
| Peptide_Sequence | XYAGX |
| Peptide_Length | 5 |
| Non-standard residues | Yes |
Interaction Information
| PDB_ID | 6WX4 |
|---|---|
| Method | X-RAY DIFFRACTION |
| Resolution | 1.66 angstrom |
| Structure | |
| Protein-peptide residue interaction | |
| Interaction_xlsx | Download interaction table (.xlsx) |
Reference Information
| Title | Activity profiling and crystal structures of inhibitor-bound SARS-CoV-2 papain-like protease: A framework for anti-COVID-19 drug design. |
|---|---|
| Release_Year | 2020 |
| PMID | 33067239 |
| DOI | 10.1126/sciadv.abd4596 |